Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis

Clinical trial NCT06430671 · COMPLETED

Trial details

NCT number: NCT06430671
Sponsor: Cellerys AG
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsing-remitting Multiple Sclerosis (RRMS)

Start date: 2024-06-18
Primary completion: 2025-12-23
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.